These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 7097457)
1. Statistical methods in parenteral drug research. III. Discrete statistical distribution functions and tests of hypotheses. Porter WR J Parenter Sci Technol; 1982; 36(3):134-40. PubMed ID: 7097457 [No Abstract] [Full Text] [Related]
2. Statistical methods in parenteral drug research IV. Continuous statistical distribution functions, confidence limits, and tests of normality. Porter WR J Parenter Sci Technol; 1982; 36(4):179-87. PubMed ID: 7131211 [No Abstract] [Full Text] [Related]
3. Sample size and the probability of a successful trial. Chuang-Stein C Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428 [TBL] [Abstract][Full Text] [Related]
4. Are generics a drug on the market? Tyler VE J Indiana State Med Assoc; 1980 Jul; 73(7):452-7. PubMed ID: 7452036 [No Abstract] [Full Text] [Related]
5. In vitro bioequivalence testing. Chow SC; Shao J; Wang H Stat Med; 2003 Jan; 22(1):55-68. PubMed ID: 12486751 [TBL] [Abstract][Full Text] [Related]
6. Tests for individual and population bioequivalence based on generalized p-values. McNally RJ; Iyer H; Mathew T Stat Med; 2003 Jan; 22(1):31-53. PubMed ID: 12486750 [TBL] [Abstract][Full Text] [Related]
8. [Guidelines for the evaluation of publications, testimonies and other data on the therapeutic value of drugs]. Anaesthesist; 1969 Jul; 18(7):232-3. PubMed ID: 5361123 [No Abstract] [Full Text] [Related]
9. Descriptive tools and analysis. Capellà D WHO Reg Publ Eur Ser; 1993; 45():55-78. PubMed ID: 8442851 [No Abstract] [Full Text] [Related]
10. The present volume is base on the "Integrating Systems Approaches into Pharmaceutical Sciences" conference held in Basel in 2007. Preface. Goryanin I; Lebedeva G Eur J Pharm Sci; 2009 Jan; 36(1):1-3. PubMed ID: 19038334 [No Abstract] [Full Text] [Related]
11. Current product equivalency issues. Gerrard TL Food Drug Law J; 1995; 50(3):451-3. PubMed ID: 10343011 [No Abstract] [Full Text] [Related]
12. On the stochastic modeling of tracer kinetics. Matis JH; Tolley HD Fed Proc; 1980 Jan; 39(1):104-9. PubMed ID: 7351238 [TBL] [Abstract][Full Text] [Related]
13. Determining drug equality. Hecht A FDA Consum; 1975 Nov; 9(9):18-20. PubMed ID: 10316633 [No Abstract] [Full Text] [Related]
14. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion. Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966 [No Abstract] [Full Text] [Related]
15. Tutorial on discrete hazard functions. Alemi F Qual Manag Health Care; 2007; 16(4):311-20. PubMed ID: 18049384 [TBL] [Abstract][Full Text] [Related]
16. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
17. [Principles of statistical methodology in medicine XII. Interpretation of results in statistical tests]. Holcík J; Gerylovová A Vnitr Lek; 1975 Jul; 21(7):724-8. PubMed ID: 1146245 [No Abstract] [Full Text] [Related]
18. 25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel. Grieve AP Pharm Stat; 2007; 6(4):261-81. PubMed ID: 17955514 [TBL] [Abstract][Full Text] [Related]